SELLAS Life Sciences Group, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for SELLAS Life Sciences Group, Inc. (SLS) is 1.63B

According to SELLAS Life Sciences Group, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.63B. This represents a change of 66.37% compared to the average of 978.73M of the last 4 quarters.

SELLAS Life Sciences Group, Inc. (SLS) Historical Enterprise Value (quarterly & annually)

How has SLS Enterprise Value performed in the past?

The mean historical Enterprise Value of SELLAS Life Sciences Group, Inc. over the last ten years is 60.81M. The current 1.63B Enterprise Value has changed 2.58% with respect to the historical average. Over the past ten years (40 quarters), SLS's Enterprise Value was at its highest in in the June 2026 quarter at 2.65B. The Enterprise Value was at its lowest in in the June 2019 quarter at -9391000.00.

SELLAS Life Sciences Group, Inc. (SLS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of SELLAS Life Sciences Group, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SELLAS Life Sciences Group, Inc. (SLS) Average Enterprise Value

How has SLS Enterprise Value performed in the past?

The current Enterprise Value of SELLAS Life Sciences Group, Inc. (SLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

SELLAS Life Sciences Group, Inc. (SLS) Enterprise Value vs. Peers

How is SLS’s Enterprise Value compared to its peers?

SELLAS Life Sciences Group, Inc.’s Enterprise Value is greater than ArriVent BioPharma, Inc. (532.53M), less than Incyte Corporation (20.93B), greater than MacroGenics, Inc. (79.80M), less than Nurix Therapeutics, Inc. (2.17B), less than Immunome, Inc. (2.08B), less than Ascentage Pharma Group International (8.68B), greater than Prelude Therapeutics Incorporated (152.10M), less than IDEAYA Biosciences, Inc. (2.78B), greater than Crescent Biopharma, Inc. (308.64M), greater than C4 Therapeutics, Inc. (383.00M),

Build a custom stock screener for SELLAS Life Sciences Group, Inc. (SLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SELLAS Life Sciences Group, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SELLAS Life Sciences Group, Inc. (SLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SELLAS Life Sciences Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.